Apple avoids a second import ban for its redesigned smartwatches in latest court ruling

The US International Trade Commission terminated Masimo's case seeking a second import ban on redesigned Apple Watches, ruling Apple's reworked blood-oxygen monitoring technology doesn't infringe Masimo's patents. This follows a 2021 patent dispute where ITC initially banned Apple Watches, forcing Apple to redesign the feature. Masimo can appeal to the Federal Circuit. Separately, a federal jury awarded Masimo $634 million against Apple in November for patent infringement.